Unreported / Non-Citable
Background
Plaintiff Lubricote, LLC sued Lumenis Be Ltd. for infringing U.S. Patent No. 10,335,232, which covers a non-invasive, pulsed lighting device used to treat eye conditions. Lubricote alleges that Lumenis’s OptiLIGHT device infringes this patent. The suit was filed in the Eastern District of Texas.
Lumenis, an Israeli corporation, subsequently filed a motion to transfer the case to the Central District of California (CDCA), arguing that it would be a more convenient forum. Lubricote, the plaintiff, is based in the CDCA, though Lumenis itself has no direct connection to that district. Lumenis’s U.S. subsidiary, which sells the accused product, is located in the Northern District of California.
The Court’s Holding
The U.S. District Court for the Eastern District of Texas DENIED Lumenis’s Motion to Transfer. The court found that Lumenis failed to meet the threshold requirement for transfer under 28 U.S.C. § 1404(a), which mandates that the case “might have been brought” in the proposed transferee district. Specifically, Lumenis did not establish that the CDCA would have personal jurisdiction over it.
Even if Lumenis had satisfied this threshold, the court independently reviewed the private and public interest factors for convenience and found they did not “clearly show” that the CDCA would be more convenient than the Eastern District of Texas. The court emphasized that Lumenis could not rely on Lubricote’s convenience in the CDCA to justify the transfer, especially since Lubricote chose to file suit in Texas. The court noted that evidence in patent cases often originates from the accused infringer, whose product development and sales were largely outside the CDCA, including Israel, Texas, and Tennessee.
Key Takeaways
- A defendant seeking transfer under 28 U.S.C. § 1404(a) must first establish that the case “could have been brought” in the transferee district, including demonstrating personal jurisdiction over themselves in that forum.
- A defendant cannot successfully argue for transfer by citing the plaintiff’s convenience in the proposed transferee forum, as a plaintiff’s choice of forum is given deference.
- In patent infringement cases, the location of the accused infringer’s evidence (e.g., product design, manufacturing, sales, and relevant witnesses) is a critical factor in the convenience analysis for venue.
- Delay in filing a motion to transfer, such as seven months after the initial lawsuit, can weigh against granting the transfer.
Why It Matters
This ruling provides important guidance for defendants contemplating motions to transfer, particularly in patent litigation. It underscores the stringent requirements for proving both that the alternative forum is a proper venue and that it is “clearly more convenient.” The decision highlights that courts will not entertain speculative arguments about a plaintiff’s convenience in an alternative forum, thereby safeguarding a plaintiff’s initial choice of venue.
For patent holders, the decision reaffirms the ability to strategically choose a forum, provided jurisdictional and venue requirements are met. For accused infringers, it signals that transfer motions must be robustly supported by evidence demonstrating their own inconvenience in the chosen forum and the clear superiority of the alternative, rather than merely pointing to the plaintiff’s connections elsewhere.